DoW Peer Reviewed Medical, Research Advancement Award
About
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals. Distinctive Features: Applications must include preliminary data. The Research Advancement Award supports use-inspired basic research to further or validate preliminary findings for short- and long-term impact. Proposed research projects may range from hypothesis testing to expansion of mature data. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $19.6M to fund approximately 14 Research Advancement Award applications with total cost caps of $1.4M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
The DoW Peer Reviewed Medical Research Advancement Award, administered through the Congressionally Directed Medical Research Programs (CDMRP), is designed for researchers and medical institutions seeking to advance fundamental research studies that will significantly contribute to understanding diseases, improving patient care, and enhancing quality of life. This award specifically supports use-inspired basic research that builds upon preliminary findings, making it ideal for researchers with promising initial data who need funding to validate, expand, or further develop their hypotheses. The program is particularly valuable for investigators working on congressionally directed FY26 PRMRP topic areas who align their research with portfolio-specific strategic goals. With approximately $19.6 million allocated across roughly 14 awards, individual grants can reach up to $1.4 million over a maximum 4-year performance period, providing substantial support for research advancement. This funding opportunity is essential for medical researchers looking to bridge the gap between preliminary findings and mature data, supporting projects ranging from hypothesis testing to expansion of established research. Applicants should have preliminary data demonstrating the feasibility and importance of their proposed research directions.
Funding Facts
● Applications openDeadline
July 30, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Up to $1.4 million per award
Deadline
2026-07-30
Grant Type
federal
Application Cycle
Annual (FY26 cycle, deadline July 30, 2026)
Best For
Medical researchers with preliminary data seeking to validate, expand, or advance fundamental research aligned with congressionally directed topic areas
Frequently Asked Questions
Who is eligible for DoW Peer Reviewed Medical, Research Advancement Award?
Specific eligibility criteria are not detailed in the current program information. However, this award is intended for researchers conducting medical research aligned with congressionally directed FY26 PRMRP topic areas. For comprehensive eligibility requirements, application restrictions, and institutional qualifications, please consult the official CDMRP website or the detailed Funding Opportunity Announcement.
How much funding does DoW Peer Reviewed Medical, Research Advancement Award provide?
Individual Research Advancement Awards can receive up to $1.4 million in total costs. The FY26 funding cycle allocates approximately $19.6 million across roughly 14 awards. The maximum period of performance is 4 years. For current funding amounts in future cycles, check the official CDMRP announcement.
How do I apply for DoW Peer Reviewed Medical, Research Advancement Award?
Applications for the DoW Peer Reviewed Medical Research Advancement Award must include preliminary data demonstrating the feasibility of your proposed research. The application deadline for FY26 is July 30, 2026. Submission details, application portal access, and specific formatting requirements are available through the official CDMRP website. Applications should clearly align with congressionally directed topic areas and portfolio-specific strategic goals.
What can DoW Peer Reviewed Medical, Research Advancement Award funding be used for?
This award supports use-inspired basic research that furthers or validates preliminary findings with both short- and long-term impact potential. Funding can support research projects ranging from hypothesis testing to expansion of mature data. Research must contribute to understanding diseases or conditions related to congressionally directed FY26 PRMRP topic areas and advance patient care or quality of life outcomes.
Last updated: July 5, 2026